ResMed Quarterly Balance Sheet
NYSE: RMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ResMed financial position
As of Jun 30, 2026, ResMed reported total assets of $8.97 billion, up 9.7% from a year earlier against total liabilities of $2.38 billion. Shareholders' equity stood at $6.59 billion, or 73.4% of assets. The company held $1.47 billion in cash and equivalents against $659.4 million of debt, a net cash position of $809.9 million.
The current ratio (current assets divided by current liabilities) was 3.10, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.10.
Summary generated from market data by MetaCap's automated system. Methodology
ResMed balance sheet (quarterly)
| Quarter (USD) | Q4 20262026-06-30 | Q3 20262026-03-31 | Q2 20262025-12-31 | Q1 20262025-09-30 | Q4 20252025-06-30 | Q3 20252025-03-31 | Q2 20252024-12-31 | Q1 20252024-09-30 | Q4 20242024-06-30 | Q3 20242024-03-31 | Q2 20242023-12-31 | Q1 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.47B | 1.66B | 1.42B | 1.38B | 1.21B | 932.71M | 521.94M | 426.36M | 238.36M | 237.91M | 210.25M | 209.10M |
| Receivables | 1.04B | 998.84M | 985.63M | 907.27M | 939.49M | 907.83M | 859.94M | 811.20M | 837.27M | 779.26M | 729.74M | 692.39M |
| Inventory | 945.80M | 911.88M | 922.04M | 945.81M | 927.71M | 862.64M | 882.10M | 917.98M | 822.25M | 829.46M | 933.21M | 958.23M |
| Total Current Assets | 4.32B | 4.06B | 3.82B | 3.63B | 3.51B | 3.21B | 2.84B | 2.64B | 2.36B | 2.35B | 2.38B | 2.30B |
| Property, Plant & Equipment | 581.83M | 566.97M | 564.25M | 563.63M | 550.79M | 535.34M | 520.16M | 560.21M | 548.02M | 539.74M | 551.73M | 533.99M |
| Goodwill | 2.91B | 3.04B | 3.04B | 3.04B | 3.05B | 2.85B | 2.81B | 2.89B | 2.84B | 2.84B | 2.86B | 2.81B |
| Intangible Assets | 452.74M | 425.19M | 430.24M | 447.07M | 464.86M | 430.11M | 438.00M | 478.61M | 485.90M | 501.02M | 528.18M | 563.28M |
| Total Assets | 8.97B | 8.78B | 8.50B | 8.31B | 8.17B | 7.57B | 7.14B | 7.22B | 6.87B | 6.81B | 6.91B | 6.74B |
| Accounts Payable | 308.92M | 273.30M | 250.41M | 266.77M | 278.16M | 222.56M | 220.31M | 249.28M | 237.73M | 177.44M | 202.40M | 177.05M |
| Short-Term Debt | 259.95M | 259.93M | 259.91M | 259.90M | 9.90M | 9.91M | 9.91M | 9.90M | 9.90M | 9.90M | 9.90M | 9.90M |
| Total Current Liabilities | 1.40B | 1.35B | 1.25B | 1.26B | 1.02B | 940.52M | 851.96M | 904.08M | 910.65M | 773.03M | 764.07M | 770.80M |
| Long-Term Debt | 399.42M | 404.17M | 403.92M | 408.66M | 658.39M | 663.13M | 662.86M | 667.58M | 697.31M | 997.05M | 1.22B | 1.35B |
| Total Liabilities | 2.38B | 2.29B | 2.18B | 2.19B | 2.21B | 2.02B | 1.89B | 2.03B | 2.01B | 2.18B | 2.42B | 2.49B |
| Shareholders' Equity | 6.59B | 6.49B | 6.32B | 6.12B | 5.97B | 5.55B | 5.25B | 5.20B | 4.86B | 4.63B | 4.48B | 4.25B |
| Retained Earnings | 7.26B | 6.96B | 6.65B | 6.34B | 6.08B | 5.78B | 5.49B | 5.23B | 4.99B | 4.77B | 4.54B | 4.40B |
| Total Debt | 659.37M | 664.10M | 663.83M | 668.56M | 668.29M | 673.03M | 672.76M | 677.47M | 707.21M | 1.01B | 1.23B | 1.36B |
| Net Cash (Debt) | 809.87M | 996.42M | 753.24M | 715.29M | 541.16M | 259.68M | -150.82M | -251.11M | -468.85M | -769.04M | -1.02B | -1.15B |
| Shares Outstanding | 144.24M | 145.04M | 145.66M | 145.94M | 146.39M | 146.62M | 146.86M | 146.78M | 146.90M | 146.89M | 147.09M | 147.09M |
This table shows 12 quarterly periods of ResMed's balance sheet, from Q4 2026 back to Q1 2024, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow RMD's reporting calendar. What is a balance sheet?